Clinical TrialID 5316
A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea
NCT03193372
Rosacea
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 5316
- Evidence Id
- 5316
- Core Evidence Id
- 5316
- Source Clinical Trial Id
- 5301
- Herb2 Clinical Trial Id
- HBCT005301
- Nct Id
- NCT03193372
- Title
- A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- Rosacea
- Study Type
- Observational
- Study Design
- Observational Model: |Time Perspective: p
- Intervention
- DRUG: Azelaic Acid (Finacea Foam, BAY39-6251)
- Intervention Allocation
- Intervention Model
- Intervention Mask
- Intervention Purpose
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 2200
- Outcome Measure
- Demographics and clinical characteristics, Collected patient demographics and characteristics are : * Year of birth * Gender * Insurance type, one-time survey in 2 week recruitment window|Rosacea-relevant comorbidities and complications, Patient reported history of the following will be collected : * Blepharitis * Conjunctivitis * Corneal neovascularization/keratitis * Depression * Migraine, one-time survey in 2 week recruitment window|Rosacea subtype, Patient reported diagnosis of the following will be collected: * Erythematotelangiectatic (facial redness) * Papulopustular (bumps and pimples) * Phymatous (enlargement of the nose) * Ocular (eye irritation) * Unknown, one-time survey in 2 week recruitment window|Past use of topical rosacea treatments, Patient reported use of the following medications will be collected: * Metronidazole gel * Metronidazole cream * Metronidazole lotion * Metronidazole emulsion * Brimonidine tartrate gel, one-time survey in 2 week recruitment window|Patient concerns collected by Rosacea Treatment Preference Questionnaire, Rosacea Treatment Preference Questionnaire is a survey to assess patient self-reported rosacea subtype and severity, and to evaluate the concerns that contribute to patient satisfaction/dissatisfaction, as well as treatment decisions with rosacea topical treatments, one-time survey in 2 week recruitment window|Treatment satisfaction assessed by Satisfaction with Medicines Questionnaire (SATMED-Q), SATMED-Q is a 17-question, validated, multidimensional generic questionnaire designed for use in patients with any chronic disease treated with medicines, one-time survey in 2 week recruitment window|Quality of life measured by Dermatology Life Quality Index (DLQI), DLQI is a widely used dermatology-related quality of life tool, one-time survey in 2 week recruitment window
- Sponsor Collaborator
- LEO Pharma|Bayer
- Funded By
- INDUSTRY
- Location
- Xcenda, LLC, Palm Harbor, Florida, 34685, United States
- Other Id
- 19638
- Start Date
- 2017-07-20
- Primary Completion Date
- 2017-08-08
- Completion Date
- 2017-11-15
- First Posted
- 2017-06-20
- Results First Posted
- Last Update Posted
- 2020-04-01
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT03193372
- Title Cn
- Title En
- A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea
- Bilingual Status
- semi_complete